ELCC 2018 | The importance of precision immunotherapy: cost, benefit & toxicity

In recent years, there has been a massive increase in the number of different immunotherapeutic agents that can be used in the treatment of cancer. In this interview, Giorgio Scagliotti, MD, PhD, from the University of Turin, Turin, Italy, discusses why it is important that patients are only receiving the most appropriate therapy for their specific form of cancer, in terms of side-effects and the high cost of many of these drugs. This interview was conducted at the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland.